Our expanding knowledge of cancer genomes has led to the development of more-effective therapeutic strategies. Tumor profiling has shown clinical benefits to improve precision medicine. Circulating tumor DNA shed from the tumor into the body fluids open up tremendous opportunities for safe, more-effective noninvasive cancer management across different cancer types.
The focus of the Tsui lab is to study the molecular profiles of cancer using circulating tumor DNA and other nucleic acids in plasma and body fluids for noninvasive management of treatment responses and guiding personalized medicine.
Research FocusMolecular geneticist Dana Tsui studies circulating tumor DNA and other nucleic acids in plasma and body fluids for noninvasive molecular diagnostics.
- Cancer Research UK Cambridge Institute, University of Cambridge, UK (Mentor: Nitzan Rosenfeld), Postdoctoral
- Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong (Mentor: Dennis YM Lo), Doctoral
- Tsui DW, Berger MF. Profiling Non-Small Cell Lung Cancer: From Tumor to Blood. Clin Cancer Res. 2016 Feb 15;22(4):790-2. doi: 10.1158/1078-0432.CCR-15-2514.
- Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin SF, Tsui DW, Marass F, Gale D, Ali HR, Shah P, Contente-Cuomo T, Farahani H, Shumansky K, Kingsbury Z, Humphray S, Bentley D, Shah SP, Wallis M, Rosenfeld N, Caldas C. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun. 2015 Nov 4;6:8760. doi: 10.1038/ncomms9760.
- Cancer Research UK Research Travel Award, 2015
- IASLC World Conference on Lung Cancer Young Investigator Award, 2015
- Elected as a Junior Research Fellow of Wolfson College, University of Cambridge, UK, 2014
- European Association for Cancer Research (EACR) Non-Student Travel Award, 2014
- British Association for Cancer Research (BACR) Non-Student Travel Award , 2013
- Susan G. Komen for the Cure Scholarship Award, 2012